Upexi (UPXI) priced a secondary stock offering Monday to raise $100 million by selling 43.9 million shares at $2.28 each.
The stock soared more than sixfold as intraday volume topped 89.5 million shares versus the daily average of almost 140,000.
ReShape Lifesciences (RSLS) said the US Patent and Trademark Office awarded a notice of allowance for its proprietary diabetes neuromodulation technology, under patent application, titled high-frequency low duty cycle patterns for neural regulation.
The stock surged 33% as volume topped 142.3 million versus the daily average of about 13.1 million.
Forge Global Holdings (FRGE) shares rose 38%, a session after the company made a nonbinding offer to acquire privately held asset manager Accuidity.
Volume topped 635,000 versus the daily average of almost 69,000.
Price: 14.63, Change: +12.36, Percent Change: +544.27
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.